Our Services
Medical Information
Helpful Resources
Published on: 9/24/2026
Both are weekly combination hormonal birth control patches, but they differ in the specific progestin and estrogen doses they deliver, which can affect side effects, bleeding patterns, blood clot risk, weight or BMI limits, and how each one fits your health history. Cost, insurance coverage, and generic availability can also set them apart, so the "better" option is highly individual. There are several important factors to weigh, including effectiveness with typical use and who should avoid estrogen entirely, and those details are explained below.
If you are noticing spotting, nausea, headaches, mood changes, or other symptoms while using a patch, it helps to know whether it is a common adjustment effect or a sign that needs prompt attention. Take a free, instant, online symptom check to better understand what may be driving your symptoms and what to discuss at your next visit.
Last reviewed for medical accuracy: 09/24/2026
Choosing the right birth control means balancing effectiveness, side effects, cost and personal lifestyle. Gwyn Lo and Xulane are two popular hormonal options—but they work very differently. This guide lays out what you need to know to compare Gwyn Lo vs Xulane in plain, clear language.
Gwyn Lo is a levonorgestrel-releasing intrauterine device (IUD). Key points:
Xulane is a transdermal patch combining estrogen and progestin. Overview:
| Method | Perfect Use | Typical Use* |
|---|---|---|
| Gwyn Lo IUD | > 99% | ~ 99% |
| Xulane | > 99% | ~ 91% |
*Typical use accounts for occasional missed or mis-timed doses (or patch changes). The IUD’s “set-and-forget” nature makes typical use failure rates very low compared to user-dependent methods.
– Disadvantages
– Disadvantages
Always check with your insurer or provider office for exact pricing.
If you experience any of the following, remove the patch (if applicable) and contact a provider right away—or do a free, online symptom check, using the doctor approved Ubie Symptom Checker:
Always speak to a doctor about anything that could be life threatening or serious.
When weighing Gwyn Lo vs Xulane, consider:
Both methods are highly effective when used correctly. Discuss your health history, lifestyle and personal preferences with a health care provider to make the best choice for you. And remember: speak to a doctor about anything that could be life threatening or serious.
(References)
* Creasy GW, Fisher AC, Hall N, Shangold GA. Transdermal contraceptive patch delivering norelgestromin and ethinyl estradiol. Effects on the lipid profile. J Reprod Med. 2003 Mar;48(3):179-86. PMID: 12698776.
* Calderoni ME, Coupey SM. Combined hormonal contraception. Adolesc Med Clin. 2005 Oct;16(3):517-37. doi: 10.1016/j.admecli.2005.05.001. PMID: 16183537.
* Taneepanichskul S. Norelgestromin/ethinyl estradiol transdermal system. J Med Assoc Thai. 2005 Oct;88 Suppl 2:S82-4. PMID: 17722322.
* Sriprasert I, Stanczyk FZ, Archer DF. Ethinyl estradiol and levonorgestrel in a transdermal contraceptive delivery system. Expert Opin Pharmacother. 2015;16(12):1901-9. doi: 10.1517/14656566.2015.1056733. PMID: 26194214.
* Hashimoto N, Nakamichi N, Yamazaki E, Oikawa M, Masuo Y, Schinkel AH, Kato Y. P-Glycoprotein in skin contributes to transdermal absorption of topical corticosteroids. Int J Pharm. 2017 Apr 15;521(1-2):365-373. doi: 10.1016/j.ijpharm.2017.02.064. Epub 2017 Feb 24. PMID: 28242377.
* DE Leo V, Cianci A, DI Carlo C, Cappelli V, Fruzzetti F. [Customization of hormonal contraception]. Minerva Ginecol. 2018 Feb;70(1):1-26. doi: 10.23736/S0026-4784.17.04157-0. PMID: 29347814.
* Contraceptives, Oral, Combined. 2006. PMID: 30000354.
* Baker CC, Chen MJ. New Contraception Update - Annovera, Phexxi, Slynd, and Twirla. Curr Obstet Gynecol Rep. 2022 Mar;11(1):21-27. doi: 10.1007/s13669-021-00321-4. Epub 2022 Jan 6. PMID: 35795653; PMCID: PMC9255890.
* Meczekalski B, Rasi M, Battipaglia C, Fidecicchi T, Bala G, Szeliga A, Luisi S, Genazzani AD. PCOS and Obesity: Contraception Challenges. Open Access J Contracept. 2025;16:43-58. doi: 10.2147/OAJC.S501434. Epub 2025 May 5. PMID: 40352401; PMCID: PMC12063626.
* Patel VP, Collins K, Heinemann K, Ngantung W, Saeedian M. A five-year cost-consequence analysis of extended-use etonogestrel implant versus other contraceptives. J Med Econ. 2026 Dec;29(1):66-76. doi: 10.1080/13696998.2025.2606600. Epub 2025 Dec 29. PMID: 41460288.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.